{
    "title": "US FDA declines to approve Eli Lilly's bowel disease drug",
    "url": "https://www.dailymail.co.uk/wires/reuters/article-11970677/US-FDA-declines-approve-Eli-Lillys-bowel-disease-drug.html",
    "date": "2023-04-13",
    "keywords": [
        "drug",
        "fda",
        "disease",
        "inc",
        "health",
        "regulator",
        "manufacturing",
        "company",
        "analyst",
        "thursday",
        "food",
        "administration",
        "type",
        "inflammatory",
        "bowel",
        "decision",
        "market",
        "abbvie",
        "pfizer",
        "johnson",
        "amp",
        "package",
        "safety",
        "label",
        "medicine",
        "latestage",
        "growth",
        "decade",
        "issue",
        "setback",
        "context",
        "portfolio",
        "eli",
        "dont",
        "morningstar",
        "damien",
        "conover",
        "approval",
        "treatment",
        "colitis",
        "condition",
        "immune",
        "system",
        "cause",
        "inflammation",
        "lining",
        "colon",
        "passing",
        "blood",
        "stool",
        "pain",
        "possibility",
        "product",
        "mohit",
        "bansal",
        "note",
        "year",
        "nod",
        "donanemab",
        "launch",
        "tirzepatide",
        "obesity",
        "lebrikizumab",
        "atopic",
        "dermatitis",
        "eczema",
        "cancer",
        "reporting",
        "raghav",
        "mahobe",
        "bhanvi",
        "satija",
        "roy",
        "bengaluru",
        "editing",
        "rashmi",
        "aich",
        "anil",
        "dsilva"
    ],
    "category": [
        "wires",
        "reuters"
    ]
}